Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer.
Beckabir W, Zhou M, Lee JS, Vensko SP, Woodcock MG, Wang HH, Wobker SE, Atassi G, Wilkinson AD, Fowler K, Flick LM, Damrauer JS, Harrison MR, McKinnon KP, Rose TL, Milowsky MI, Serody JS, Kim WY, Vincent BG.
Beckabir W, et al. Among authors: woodcock mg.
Nat Commun. 2024 May 24;15(1):4448. doi: 10.1038/s41467-024-48480-1.
Nat Commun. 2024.
PMID: 38789460
Free PMC article.
Clinical Trial.